These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 10385671
1. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Yamamoto M, Hayashi N, Takehara T, Ueda K, Mita E, Tatsumi T, Sasaki Y, Kasahara A, Hori M. Hepatology; 1999 Jul; 30(1):300-7. PubMed ID: 10385671 [Abstract] [Full Text] [Related]
2. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein. Han J, Pan X, Gao Y, Weil L. Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370 [Abstract] [Full Text] [Related]
3. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Delaney WE, Isom HC. Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254 [Abstract] [Full Text] [Related]
4. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T. Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275 [Abstract] [Full Text] [Related]
5. Intracellular-delivery of a single-chain antibody against hepatitis B core protein via cell-penetrating peptide inhibits hepatitis B virus replication in vitro. Xun Y, Pan Q, Tang Z, Chen X, Yu Y, Xi M, Zang G. Int J Mol Med; 2013 Feb; 31(2):369-76. PubMed ID: 23241903 [Abstract] [Full Text] [Related]
6. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpens P, Peterson DL, Milich DR, Leroux-Roels G, Sällberg M. J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303 [Abstract] [Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
8. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Scand J Gastroenterol; 2008 May; 43(7):849-56. PubMed ID: 18584524 [Abstract] [Full Text] [Related]
9. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S. J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [Abstract] [Full Text] [Related]
10. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL, Pan JS, Cheng T, Dong J, Lu YP, Huang SJ, Shi HX, Wang L, Lian YM. Chin J Dig Dis; 2006 Dec; 7(4):230-6. PubMed ID: 17054586 [Abstract] [Full Text] [Related]
11. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity. Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH. J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848 [Abstract] [Full Text] [Related]
12. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. BouHamdan M, Kulkosky J, Duan LX, Pomerantz RJ. J Hum Virol; 2000 Apr; 3(1):6-15. PubMed ID: 10774802 [Abstract] [Full Text] [Related]
13. Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Gerber MA, Sells MA, Chen ML, Thung SN, Tabibzadeh SS, Hood A, Acs G. Lab Invest; 1988 Aug; 59(2):173-80. PubMed ID: 2841537 [Abstract] [Full Text] [Related]
14. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA]. Yao YQ, Zhang DF, Luo Y, Zhang DZ, Huang AL, Wang B, Zhou WP, Ren H, Guo SH. Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138 [Abstract] [Full Text] [Related]
15. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells. Ren X, Luo G, Xie Z, Zhou L, Kong X, Xu A. J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826 [Abstract] [Full Text] [Related]
16. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Gong ZJ, De Meyer S, van Pelt J, Hertogs K, Depla E, Soumillion A, Fevery J, Yap SH. Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938 [Abstract] [Full Text] [Related]
17. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [Abstract] [Full Text] [Related]
18. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Shin D, Kim SI, Kim M, Park M. Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303 [Abstract] [Full Text] [Related]
19. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice. Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF. Chin Med J (Engl); 2005 Aug 20; 118(16):1351-6. PubMed ID: 16157029 [Abstract] [Full Text] [Related]
20. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Konishi M, Wu CH, Wu GY. Hepatology; 2003 Oct 20; 38(4):842-50. PubMed ID: 14512871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]